Skip to main content

Month: August 2021

Middlefield Banc Corp. Announces 2021 Third Quarter Cash Dividend Payment

MIDDLEFIELD, Ohio, Aug. 10, 2021 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today announced that the Company’s Board of Directors declared a quarterly cash dividend of $0.16 per common share, payable on September 15, 2021, to shareholders of record on September 3, 2021. About Middlefield Banc Corp. Middlefield Banc Corp., headquartered in Middlefield, Ohio, is the bank holding company of The Middlefield Banking Company with total assets of $1.36 billion at June 30, 2021. The bank operates 16 full-service banking centers and an LPL Financial® brokerage office serving Beachwood, Chardon, Cortland, Dublin, Garrettsville, Mantua, Middlefield, Newbury, Orwell, Plain City, Powell, Solon, Sunbury, Twinsburg, and Westerville. The Bank also operates a Loan Production Office in Mentor, Ohio.   Additional information is available...

Continue reading

AYRO Receives Additional $2.9 Million Purchase Order for Club Car Current EV

The purchase orders for the Club Car Current total $4.9 million to date, demonstrating rapidly increasing demand for the newly-launched, purpose-built electric delivery vehicle in 2021 AUSTIN, TEXAS, Aug. 10, 2021 (GLOBE NEWSWIRE) — AYRO, Inc. (NASDAQ: AYRO), a designer and manufacturer of purpose-built, short-haul, and last-mile delivery electric vehicles (EVs), today announced the receipt of an additional purchase order valued at $2.9 million for the 2022 Club Car Current. This comes nearly two months after the announcement of the initial $2 million purchase order for the Club Car Current and brings total orders to $4.9 million to date since the product’s introduction in June 2021, demonstrating strong demand for this compact and customizable delivery EV. The Club Car Current fills the gap between full-sized trucks and small...

Continue reading

Cannabis Science Inc., Successfully Launches its $CSI Cannabis Science Coin for its CSi-EDP Utility Project Valuation Tracking

https://cannabissciencecoin.com/ All CSi-EDP Project Assignments Based on Project Valuations and $CSI Crypto Valuations Amsterdam, Netherlands, Aug. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Cannabis Science Inc., Formerly known as (CBIS) per its previous trading history on the OTC Markets Exchange, is very Pleased to announce it has just successfully launched its $CSI Cannabis Science Coin, Utility for CSi-EDP project asset valuation, revenue tracking, and dividend disbursements.  As well, the CSi-EDP will use the $CSI Cannabis Science Coin for several of its transaction-based products and services. Each Cannabis Science CSi-EDP product and or service assigned will become a part of the $CSI Cannabis Science Coin investment banking and economic development eco system, thus multiplying the $CSI Cannabis Science Coin value...

Continue reading

Global Care Portfolio Company, ASIC Power Company Receives Second Payment From Its First Royalty Streaming Deal

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 10, 2021 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE: HLTH, FRANKFURT: L6V2) (the “Company” or “Global Care”) a global investment company which engages in early-stage investment opportunities in private and public companies, is pleased to provide an update for its 100% owned portfolio company, ASIC Power Company (“ASIC”). Further to the press release dated July 21st, 2021, ASIC received its second royalty streaming payment for the period from July 17th until August 2nd, 2021, receiving 0.71004 Bitcoin (“BTC”) equating to approximately CDN $38,780 with a current BTC price of $54,618.04 CAD per BTC as of August 9th, 2021. Average daily revenue for ASIC’s second royalty payment increased by 23% due...

Continue reading

Pacira BioSciences Reports Preliminary Net Product Sales of $42.1 Million for July 2021

— EXPAREL momentum continues with July 2021 average daily sales at 117% of July 2020 — PARSIPPANY, N.J., Aug. 10, 2021 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported preliminary unaudited net product sales of EXPAREL® (bupivacaine liposome injectable suspension) and iovera° of $40.9 million and $1.0 million, respectively, for the month of July 2021. EXPAREL average daily sales for the month of July 2021 were 117 percent of July 2020. The company reports average daily growth rates for EXPAREL to account for differences in the number of selling days per reporting period. EXPAREL selling days were 21 in July 2021 and 23 in July 2020. “The continued growth of EXPAREL reflects its accelerating...

Continue reading

Harmony Biosciences Reports Second Quarter 2021 Financial Results and Business Updates

WAKIX® (pitolisant) Net Revenue of $73.8 Million for Second Quarter 2021 vs. $38 Million for the Same Period in 2020 Initiated Phase 2 Clinical Trial in Patients with Myotonic Dystrophy Acquired Potential First-in-Class Molecule with Novel Mechanism of Action Secured Additional Capital Through Strategic Financing Collaboration with Blackstone Conference Call and Webcast to be Held Today at 8:30 a.m. ET  PLYMOUTH MEETING, Pa., Aug. 10, 2021 (GLOBE NEWSWIRE) — Harmony Biosciences Holdings, Inc. (“Harmony” or the “Company”) (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today reported financial results and business updates for the second quarter ended June 30, 2021. “Harmony has made significant progress towards growing the company...

Continue reading

Sysco Delivers Robust Fourth Quarter Results and Raises FY22 Guidance Driven by Accelerating Sales

HOUSTON, Aug. 10, 2021 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY) today announced financial results for its 14-week fourth fiscal quarter and its fiscal year ended July 3, 2021. Key highlights for the fourth quarter of fiscal year 2021 included:Sales were stronger than expected; Share gains continue, driven by new customer wins; Sysco’s Recipe for Growth strategy advances; Inflation effectively managed; Cash flow stronger than expected, even with significant inventory investments; International operations show profit improvement; Greco and Sons transaction to close imminently; Quarterly dividend increased, maintaining Dividend Aristocrat status; and Currently no signs of Delta variant impacting demand; strong July sales.“Sysco’s fourth quarter results were strong, reflecting market share gains and industry demand that...

Continue reading

Rain Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Progress

First patient dosed in Phase 3 registrational trial (MANTRA) evaluating milademetan (RAIN-32) in patients with dedifferentiated (“DD”) liposarcoma (“LPS”) Quarter-end cash position of $164.6 million provides runway through late 2024 Management to host conference call and webcast today at 4:30PM Eastern Time NEWARK, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc., (NasdaqGS: RAIN),. (“Rain”), a late-stage company developing precision oncology therapeutics, today reports financial results for the second quarter and six months ended June 30, 2021, along with an update on the company’s key developments, business operations and upcoming milestones. “Rain has made strong progress in the second quarter and six months ended 2021,” said Avanish Vellanki, co-founder and chief executive officer of Rain. “Patients with...

Continue reading

DroneDeploy Accelerates Jobsite Automation with Acquisition of Rocos

Rocos’ technology will enable robotics to drive large-scale automation for construction, energy and agriculture SAN FRANCISCO, Aug. 10, 2021 (GLOBE NEWSWIRE) — Leading enterprise drone data company, DroneDeploy, today announced it has acquired Rocos, a New Zealand-based robotics software company. The acquisition will enable DroneDeploy customers in construction, energy, agriculture, and more to deploy and orchestrate both aerial and ground robots on their job sites. This acquisition will make physical workflow automation possible, creating more efficient and safer workplaces. “Companies are undergoing a digital transformation accelerated by challenges surrounding labor shortages and COVID-driven remote operations. As a result, the market demand for automatic site documentation and digital twins has soared,” said Mike Winn, CEO...

Continue reading

Night Vision Devices Market to Rise at 8.8% CAGR till 2027; Increasing Applications in Military and Defense Sector to Aid Growth, says Fortune Business Insights™

List of the Companies Profiled in the Market: BAE System Plc (Farnborough, United Kingdom), Leonardo S.p.A. (Rome, Italy), Thales Group (La Défense, France), Elbit Systems of America, LLC (ELBIT SYSTEMS LTD) (Fort Worth, Texas, United States), FLIR Systems, Inc. (Wilsonville, Oregon, United States), Night Vision Devices, Inc. (Pennsylvania, United States), N-Vision Optics, LLC (Massachusetts, United States), Safran Vectronix AG (Heerbrugg, Switzerland), Adams Industries, Inc. (Los Angeles, California, United States), Excelitas Technologies Corp. (Waltham, Massachusetts, United States), Opgal Optronic Industries Ltd. (Israel), Dali Technology Co., Ltd. (Zhejiang, China) Pune, India, Aug. 10, 2021 (GLOBE NEWSWIRE) — The global night vision devices market size is projected to reach USD 9.02 billion by the end of 2027. The massive...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.